← Leaderboards
Luisa Cimmino
University Of Miami School Of Medicine
$1,035,837
Attributed
$1,035,837
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $351.1K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,035,837 · 1
By mechanism
R01$1,035,837 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Rene Barro-Soria$2,957,462
- Kelvin P Lee$20,240,939
- Gaofeng Wang$1,595,249
- Thomas R Malek$20,207,638
- Richard H Kramer$20,141,505
Others in their field
Other Rising Stars on “Acute Myeloid Leukemia Cell”
- Javier Caravaca · University Of California, San Francisco$3,728,080
- Kellie Bickel · Twinstrand Biosciences, Inc.$2,555,383
- Saad J. Kenderian · Mayo Clinic Rochester$2,442,317
- Jeevisha Bajaj · University Of Rochester$2,438,184
- Bruno Di Stefano · Baylor College Of Medicine$2,398,360
- Angela Goffredo Fleischman · University Of California-Irvine$2,306,090
Research focus
Acute Myeloid Leukemia CellAdjuvantAdjuvant TherapyAdultAdult Acute Myeloblastic LeukemiaAdverse EffectsAge YearsAggressive BehaviorAllelesAlternative TreatmentAnalogAnimal ModelAntineoplastic AgentsAntioxidantsAqueousAscorbateAscorbic AcidBiological AvailabilityBone Marrow TransplantationCancer CellCell LineCell ModelChemistryAcute Myelocytic Leukemia
Grant awards (3)
Enhancing TET activity for the treatment of hematological malignancy$351,131
R01 · FY2025 · CA · contact PI
Enhancing TET activity for the treatment of hematological malignancy$333,575
R01 · FY2024 · CA · contact PI
Enhancing TET activity for the treatment of hematological malignancy$351,131
R01 · FY2023 · CA · contact PI